lapachol has been researched along with baricitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihara, M; Iida, A; Nagai, S; Sagara, M; Saito, K; Tahara, T; Watanabe, A; Yamano, Y; Yamashita, M; Yutani, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for lapachol and baricitinib
| Article | Year |
|---|---|
STAT3 inhibitory activity of naphthoquinones isolated from Tabebuia avellanedae.
Topics: Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Structure; Naphthoquinones; STAT3 Transcription Factor; Structure-Activity Relationship; Tabebuia | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |